Please ensure Javascript is enabled for purposes of website accessibility

USEC, Can You See?

By Toby Shute – Updated Apr 5, 2017 at 9:57PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The uranium handler's shares didn't enrich anyone but the short sellers yesterday.

Back in October, when I identified Shaw Group (NYSE: SGR) as a compelling nuclear option, I can't claim to have foreseen the near-term peril of investing in nuclear fuel enricher USEC (NYSE: USU). But I hope you dodged this fallout. A major project delay and cost overrun has seriously put the hurt on shares.

Before getting to the American Centrifuge Plant debacle, let's look at how USEC operates today.

Utility customers pass along uranium hexafluoride (UF6) that they've sourced from suppliers like Cameco (NYSE: CCJ) and ConverDyn, an affiliate of Honeywell (NYSE: HON). At USEC's Paducah, Ky., plant, the only enrichment facility operating in the United States, the firm separates lighter isotopes from heavier ones by means of an old process called gaseous diffusion. The process requires a tremendous amount of electricity, which accounts for 70% of the increasingly uneconomic Paducah facility's operating costs.

The end result of this process is a batch of low-enriched uranium, along with some nasty depleted uranium byproduct. USEC also purchases about half of its low-enriched uranium from dismantled Soviet-era warheads under the megatons to megawatts program. Russia has made clear its intent to raise prices in the fairly near future.

Given the power plays involved, it would behoove USEC to quickly shift toward a less energy-intensive, centrifuge-based enrichment technology, variants of which are already employed by just about everyone else in the world, save for Areva (OTC BB: ARVCF). Hence, the importance of the American Centrifuge Plant.

Contract work provided by Fluor (NYSE: FLR), McDermott (NYSE: MDR), and others is running behind schedule and over budget. With cost-reimbursement provisions in place, the suppliers do not exactly feel USEC's pain, but the firm is looking to renegotiate so that the subcontractors' interests are better aligned with its own. I don't mean to point a finger at either contractor -- labor tightness and material inflation is running amok across just about every industry that I cover for the Fool.

At the end of the day, USEC's shift to centrifuge technology will be painful, but it will happen. You hear about certain banks being too important to fail, and given its unique position in the American energy ecosystem, I would argue that the same holds true here. Whether that makes USEC a compelling buy at today's depressed prices, I'm not prepared to say, but it's certainly watch-list-worthy.

Fool contributor Toby Shute doesn't have a position in any company mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Centrus Energy Corp. Stock Quote
Centrus Energy Corp.
LEU
$36.65 (-7.38%) $-2.92
Honeywell International Inc. Stock Quote
Honeywell International Inc.
HON
$171.38 (-1.08%) $-1.87
Cameco Corporation Stock Quote
Cameco Corporation
CCJ
$25.29 (-6.37%) $-1.72
McDermott International, Inc. Stock Quote
McDermott International, Inc.
MDR
Fluor Corporation Stock Quote
Fluor Corporation
FLR
$24.75 (-3.51%) $0.90

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
329%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.